Th2-biased immune responses are important in a murine model of chronic hypersensitivity pneumonitis

International Archives of Allergy and Immunology

Volumn 154, Issue 3, 2011, Pages 264-274

  Mitaka, Keiko ^a   Miyazaki, Yasunari ^a   Yasui, Makito ^a   Furuie, Masashi ^a   Miyake, Shuji ^a   Inase, Naohiko ^a   Yoshizawa, Yasuyuki ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

A J mouse; Chronic hypersensitivity pneumonitis; Fibrogenesis; Th2

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 13; INTERLEUKIN 4; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA1;

ALLERGIC PNEUMONITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOLOGY; LUNG ALVEOLUS MACROPHAGE; LUNG ALVEOLUS WALL; LUNG FIBROSIS; LUNG LAVAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TH1 CELL; TH2 CELL;

ALVEOLITIS, EXTRINSIC ALLERGIC; ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CHRONIC DISEASE; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED STRAINS; PULMONARY FIBROSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPECIES SPECIFICITY; TH2 CELLS;

EID: 77956821630     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000321114     Document Type: Article

References (44)

1. Fink JN: Hypersensitivity pneumonitis. J Allergy Clin Immunol 1984; 74: 1-10.
2. Kaltreider HB: Hypersensitivity pneumonitis. West J Med 1993; 159: 570-578.
3. Fink JN, Barboriak JJ, Sosman AJ: Immunologic studies of pigeon breeder's disease. J Allergy 1967; 39: 214-221.
4. Ohtani Y, Saiki S, Kitaichi M, Usui Y, Inase N, Costabel U, Yoshizawa Y: Chronic bird fancier's lung: histopathological and clinical correlation. An application of the 2002 ATS/ERS consensus classification of the idiopathic interstitial pneumonias. Thorax 2005; 60: 665-671.
5. Miyazaki Y, Tateishi T, Akashi T, Ohtani Y, Inase N, Yoshizawa Y: Clinical predictors and histologic appearance of acute exacerbations in chronic hypersensitivity pneumonitis. Chest 2008; 134: 1265-1270.
6. Denis M, Cormier Y, Fournier M, Tardif J, Laviolette M: Tumor necrosis factor plays an essential role in determining hypersensitivity pneumonitis in a mouse model. Am J Respir Cell Mol Biol 1991; 5: 477-483.
7. Denis M, Cormier Y, Laviolette M: Murine hypersensitivity pneumonitis: a study of cellular infiltrates and cytokine production and its modulation by cyclosporine A. Am J Respir Cell Mol Biol 1992; 6: 68-74.
8. Butler NS, Monick MM, Yarovinsky TO, Powers LS, Hunninghake GW: Altered IL-4 mRNA stability correlates with Th1 and Th2 bias and susceptibility to hypersensitivity pneumonitis in two inbred strains of mice. J Immunol 2002; 169: 3700-3709.
9. Liu X, Kohyama T, Wang H, Zhu YK, Wen FQ, Kim HJ, Romberger DJ, Rennard SI: Th2 cytokine regulation of type I collagen gel contraction mediated by human lung mesenchymal cells. Am J Physiol 2002; 282:L1049-L1056. (Pubitemid 34654622)
10. Sempowski GD, Derdak S, Phipps RP: Interleukin-4 and interferon-gamma discordantly regulate collagen biosynthesis by functionally distinct lung fibroblast subsets. J Cell Physiol 1996; 167: 290-296. (Pubitemid 26145862)
11. Postlethwaite AE, Holness MA, Katai H, Raghow R: Human fibroblasts synthesize elevated levels of extracellular matrix proteins in response to interleukin 4. J Clin Invest 1992; 90: 1479-1485.
12. Gurujeyalakshmi G, Giri SN: Molecular mechanisms of antifibrotic effect of interferon-γ in bleomycin-mouse model of lung fibrosis: downregulation of TGF-β and procollagen I and III gene expression. Exp Lung Res 1995; 21: 791-808.
13. Hyde DM, Henderson TS, Giri SN, Tyler NK, Stovall MY: Effect of murine gamma interferon on the cellular responses to bleomycin in mice. Exp Lung Res 1988; 14: 687-704.
14. Saito A, Okazaki H, Sugawara I, Yamamoto K, Takizawa H: Potential action of IL-4 and IL-13 as fibrogenic factors on lung fibroblasts in vitro. Int Arch Allergy Immunol 2003; 132: 168-176. (Pubitemid 37409848)
15. Kishi M, Miyazaki Y, Jinta T, Furusawa H, Ohtani Y, Inase N, Yoshizawa Y: Pathogenesis of cBFL in common with IPF? Correlation of IP-10/TARC ratio with histological patterns. Thorax 2008; 63: 810-816.
16. Barrera L, Mendoza F, Zuñiga J, Estrada A, Zamora AC, Melendro EI, Ramírez R, Pardo A, Selman M: Functional diversity of T-cell subpopulations in subacute and chronic hypersensitivity pneumonitis. Am J Respir Crit Care Med 2008; 177: 44-55.
17. Ohtani Y, Kojima K, Sumi Y, Sawada M, Inase N, Miyake S, Yoshizawa Y: Inhalation provocation tests in chronic bird fancier's lung. Chest 2000; 118: 1382-1389.
18. Yoshizawa Y, Miyake S, Sumi Y, Hisauchi K, Sato T, Kurup VP: A follow-up study of pulmonary function tests, bronchoalveolar lavage cells, and humoral and cellular immunity in bird fancier's lung. J Allergy Clin Immunol 1995; 96: 122-129.
19. Ashcroft T, Simpson JM, Timbrell V: Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J Clin Pathol 1988; 41: 467-470. (Pubitemid 18098428)
20. Coligan JE: Current Protocols in Immunology. New York, Wiley and Sons, 1997, pp 1-9.
21. Ohtani Y, Inase N, Miyake S, Yoshizawa Y, Saiki S: Fatal outcome in chronic bird fancier's lung. Am J Med 2002; 112: 588-590. (Pubitemid 34518324)
22. Greenberger PA, Pien LC, Patterson R, Robinson P, Roberts M: End-stage lung and ultimately fatal disease in a bird fancier. Am J Med 1989; 86: 119-122. (Pubitemid 19039549)
23. Tasaka S, Kanazawa M, Kawai C, Soejima K, Yamaguchi K, Takata A, Torikata C, Hata J: Fatal diffuse alveolar damage from bird fancier's lung. Respiration 1997; 64: 307-309. (Pubitemid 27277849)
24. Trahan S, Hanak V, Ryu JH, Myers JL: Role of surgical lung biopsy in separating chronic hypersensitivity pneumonia from usual interstitial pneumonia/idiopathic pulmonary fibrosis: analysis of 31 biopsies from 15 patients. Chest 2008; 134: 126-132. (Pubitemid 352008773)
25. Shinagawa K, Kojima M: Mouse model of airway remodeling. Am J Respir Crit Care Med 2003; 168: 959-967.
26. Chensue SW, Terebuh PD, Warmington KS, Hershey SD, Evanoff HL, Kunkel SL, Higashi GI: Role of IL-4 and IFN-γ in Schistosoma mansoni egg-induced hypersensitivity granuloma formation. J Immunol 1992; 148: 900-910.
27. Chensue SW, Warmington K, Ruth J, Lincoln P, Kuo MC, Kunkel SL: Cytokine responses during mycobacterial and schistosomal antigen-induced pulmonary granuloma formation: production of Th1 and Th2 cytokines and relative contribution of TNF. Am J Pathol 1994; 145: 1105-1114.
28. Hogaboam CM, Blease K, Mehrad B, Steinhauser ML, Standiford TJ, Kunkel SL, Lukacs NW: Chronic airway hyperreactivity, goblet cell hyperplasia, and peribronchial fibrosis during allergic airway disease induced by Aspergillus fumigatus. Am J Pathol 2000; 156: 723-732. (Pubitemid 30643826)
29. Zhu Z, Homer RJ, Wang Z, Chen Q, Geba GP, Wang J, Zhang Y, Elias JA: Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest 1999; 103: 779-788. (Pubitemid 29152623)
30. Wynn T: Fibrotic disease and the Th1/Th2 paradigm. Nat Rev Immunol 2004; 4: 583-594.
31. Sim PJ, O' Reillly KM: Fibrosis of lung and other tissues: new concepts in pathogenesis and treatment. Clin Immunol 2001; 99: 308-319.
32. Schuyler M, Golt K, Haley P: Experimental murine hypersensitivity pneumonitis. Cell Immunol 1991; 136: 303-317.
33. + cells adoptively transfer experimental hypersensitivity pneumonitis. Am Rev Respir Dis 1992; 146: 1582-1588.
34. Schuyler M, Gott K, Freanch V: The role of IL-10 in experimental hypersensitivity pneumonitis (abstract). Am J Respir Crit Care Med 2004; 169:A83.
35. Chiaramonte MG, Mentink-Kane M, Jacobson BA, Cheever AW, Whitters MJ, Goad ME, Wong A, Collins M, Donaldson DD, Grusby MJ, Wynn TA: Regulation and function of the interleukin 13 receptor 2 during T helper cell type 2-dominant immune response. J Exp Med 2003; 197: 687-701. (Pubitemid 36350864)
36. Wills-Karp M, Luyimbazi J, Xu X, Schofield B, Neben TY, Karp CL, Donaldson DD: Interleukin-13: central mediator of allergic asthma. Science 1998; 282: 2258-2261. (Pubitemid 29004074)
37. Grünig G, Warnock M, Wakil AE, Venkayya R, Brombacher F, Rennick DM, Sheppard D, Mohrs M, Donaldson DD, Locksley RM, Corry DB: Requirement for IL-13 independently of IL-4 in experimental asthma. Science 1998; 282: 2261-2263. (Pubitemid 29004075)
38. Donaldson DD, Whitters MJ, Fitz LJ, Neben TY, Finnerty H, Henderson SL, O'Hara RM Jr, Beier DR, Turner KJ, Wood CR, Collins M: The murine IL-13 receptor alpha 2: molecular cloning, characterization, and comparison with murine IL-13 receptor alpha 1. J Immunol 1998; 161: 2317-2324. (Pubitemid 28397044)
39. Hasegawa M, Fujimoto M, Kikuchi K, Takehara K: Elevated serum levels of interleukin 4 (IL-4), IL-10, and IL-13 in patients with systemic sclerosis. J Rheumatol 1997; 24: 328-332. (Pubitemid 27104098)
40. Wynn TA, Cheever AW, Jankovic D, Poindexter RW, Caspar P, Lewis FA, Sher A: An IL-12-based vaccination method for preventing fibrosis induced by schistosome infection. Nature 1995; 376: 594-596.
41. Chiaramonte MG, Donaldson DD, Cheever AW, Wynn TA: An IL-13 inhibitor blocks the development of hepatic fibrosis during a Thelper type 2-dominanted inflammatory response. J Clin Invest 1999; 104: 777-785. (Pubitemid 29536363)
42. Fallon PG, Richardson EJ, McKenzie GJ, McKenzie AN: Schistosome infection of transgenic mice defines distinct and contrasting pathogenic roles for IL-4 and IL-13: IL-13 is a profibrotic agent. J Immunol 2000; 164: 2585-2591. (Pubitemid 30115489)
43. Shi Z, Wakil AE, Rockey DC: Strain-specific differences in mouse hepatic wound healing are mediated by divergent T helper cytokine responses. Proc Natl Acad Sci USA 1997; 94: 10663-10668. (Pubitemid 27430791)
44. Lee CG, Homer RJ, Zhu Z, Lanone S, Wang X, Koteliansky V, Shipley JM, Gotwals P, Noble P, Chen Q, Senior RM, Elias JA: Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor beta 1. J Exp Med 2001; 194: 809-821. (Pubitemid 32983016)